Clinical Trial Update: RO4929097 in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma That Can Be Removed by Surgery [Phase 2]

View source ↗

Summary

The Phase 2 clinical trial of RO4929097 for surgically removable Stage IIIB/IIIC/Stage IV melanoma sponsored by the NCI has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• RO4929097 (RO4929097)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Stage IIIB Melanoma, Stage IIIC Melanoma | Phase 2 | Status: WITHDRAWN